Protagenic Therapeutics, Inc. is a biopharmaceutical company. The Company specializes in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, is a synthetic form of Ten... Read more
SeekingAlpha
CNBC
CNBC
MarketWatch
Access detailed stock analysis from LSEG including analyst price target estimates.